Inactivating mutations of caspase-8 gene in colorectal carcinomas

Gastroenterology

Volumn 125, Issue 3, 2003, Pages 708-715

  Kim, Hong Sug ^a   Lee, Jong Woo ^a   Soung, Young Hwa ^a   Park, Won Sang ^a   Kim, Su Young ^a   Lee, Jong Heun ^a   Park, Jik Young ^a   Cho, Youg Gu ^a   Kim, Chang Jae ^a   Jeong, Seong Whan ^a   Nam, Suk Woo ^a   Kim, Sang Ho ^a   Lee, Jung Young ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8;

ADENOMA; APOPTOSIS; ARTICLE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; FRAMESHIFT MUTATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 0041323118     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)01059-X     Document Type: Article

References (31)

1. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000;39:1415-1430.
2. Nagata S, Apoptosis by death factor. Cell 1997;88:355-365.
3. Nicholson DW, Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999;6:1028-1042.
4. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ 1999;6:1060-1066.
5. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brñderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH, Möller P. Constitutive and induced expression of APO-1, a new member of the new growth factor/tumor necrosis receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-429.
6. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997;7:831-836.
7. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responses. Cancer Res 1994;54:1580-1586.
8. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997;277:818-821.
9. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999;18:3754-3760.
10. Lee SH, Shin MS, Kim HS, Lee HK, Park WS, Kim SY, Lee JH, Han SY, Park JY, Oh RR, Jang JJ, Han JY, Lee JY, Yoo NJ. Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 1999;59:5683-5686.
11. Shin MS, Kim HS, Lee SH, Lee JW, Song YH, Kim YS, Park WS, Kim SY, Lee SN, Park JY, Lee JH, Xiao W, Jo KH, Wang YP, Lee KY, Park YG, Kim SH, Lee JY, Yoo NJ. Alterations of Fas-pathway genes associated with nodal metastasis in non-small cell lung cancer. Oncogene 2002;21:4129-4136.
12. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, Lee JH, Park JY, Jang JJ, Kim CW, Kim SH, Lee JY, Lee SH. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002;99:4094-4099.
13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
14. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N. Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 1999;6:33-37.
15. Palmerini F, Devilard E, Jarry A, Birg F, Xerri L, Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol 2001;32:461-467.
16. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997;186:785-793.
17. Takita J, Yang HW, Chen YY, Hanada R, Yamamoto K, Teitz T, Kidd V, Hayashi Y. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 2001;20:4424-4432.
18. Liu B, Peng D, Lu Y, Jin W, Fan Z. A novel single amino acid deletion caspase-8 mutant in cancer cells that lost proapoptotic activity. J Biol Chem 2002;277:30159-30164.
19. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999;59:2995-3002.
20. Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dwomiczak B, Debatin KM. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001;20:5865-5877.
21. Lee JY, Dong SM, Kim SY, Yoo NJ, Lee SH, Park WS. A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch 1998;433:305-309.
22. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-827.
23. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 1996;85:803-815.
24. Blanchard H, Kodandapani L, Mittl PR, Marco SD, Krebs JF, Wu JC, Tomaselli KJ, Grutter MG. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Structure Fold Des 1999;7:1125-1133.
25. Femandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A 1996;93:7464-7469.
26. Grenet J, Teitz T, Wei T, Valentine V, Kidd VJ. Structure and chromosome localization of the human CASP8 gene. Gene 1999;226:225-232.
27. Baens M, Aerssens J, van Zand K, Van den Berghe H, Marynen P. Isolation and regional assignment of human chromosome 12p cDNAs. Genomics 1995;29:44-52.
28. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
29. Yamamoto H, Gil J, Schwartz S Jr, Perucho M. Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 2000;7:238-239.
30. Kim JC, Kim CN, Yu CS, Lee HI, Kim SW, Lee JH, Kim WK, Kang GH, Lee MK. Treatment of hepatic metastasis of colorectal cancer: a retrospective analysis of the outcome in 99 patients. J Korean Cancer Assoc 1998;30:1175-1183.
31. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, Burns D, Ng SC, Rosenberg S, Wang X. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 2003;299:223-226.